Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus

OBJECTIVE: The incidence of esophageal adenocarcinoma (EAC) is increasing, but factors contributing to malignant progression of its precursor lesion, Barrett's esophagus (BE), have not been defined. Hypergastrinemia caused by long-term use of proton pump inhibitors (PPIs), has been suggested as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoomi, Urbanska, Aleksandra M., Hayakawa, Yoku, Wang, Hongshan, Au, Andrew S., Luna, Aesis M., Chang, Wenju, Jin, Guangchun, Bhagat, Govind, Abrams, Julian A., Friedman, Richard A., Varro, Andrea, Wang, Kenneth K., Boyce, Malcolm, Rustgi, Anil K., Sepulveda, Antonia R., Quante, Michael, Wang, Timothy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352112/
https://www.ncbi.nlm.nih.gov/pubmed/27448962
http://dx.doi.org/10.18632/oncotarget.10667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352112/
https://www.ncbi.nlm.nih.gov/pubmed/27448962
http://dx.doi.org/10.18632/oncotarget.10667

Ejemplares similares